SP Group (SPG) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
9 Nov, 2026Executive summary
Q3 revenue rose 21.7% YoY; EBITDA increased 55.0% to DKK 145.2m and EBT rose 150.1% to DKK 77.8m.
9M revenue grew 12.4% to DKK 2,194.9m; EBITDA rose 38.1% to DKK 447.3m, led by own-brand sales.
Lars Bering took office as CEO; FY2024 revenue growth guidance narrowed to 10–16%.
Financial highlights
Q3 2024 revenue was DKK 710m vs. DKK 583m; EBITDA was DKK 145m vs. DKK 94m.
9M EBIT was DKK 295.8m vs. DKK 171.9m; EBT was DKK 254.2m vs. DKK 139.0m.
9M net income was DKK 198.5m vs. DKK 108.5m; diluted EPS rose to DKK 16.25 from DKK 8.90.
Financial items were a DKK 41.6m expense, up DKK 8.7m YoY, reflecting lower currency gains than in 2023.
Outlook and guidance
FY2024 revenue growth guidance narrowed to 10–16% from 8–18%; EBITDA margin guidance is 19–21% and EBT margin guidance is 11–13%.
New products and solutions, improving order intake, customer wins and growth among existing customers support further growth opportunities.
High investment levels will continue in 2024, led by a new healthcare factory and Atlanta equipment; depreciation is expected to match 2023, with higher financial expenses.
Latest events from SP Group
- Guidance held despite softer Q1 demand and heightened macroeconomic uncertainty.SPG
Q2 2023 - Earnings weakened, but guidance held as cleantech growth and new projects offered support.SPG
Q3 2023 - Lower 2023 earnings, stronger operating cash flow, and cautious growth guidance for 2024.SPG
Q4 2023 - Q1 earnings and margins rose; FY guidance held despite uncertainty.SPG
Q1 2024 - Own-brand growth lifted H1 earnings and supported higher FY2024 guidance amid uncertainty.SPG
Q2 2024 - Record revenue and margin growth in 2024, with strong outlook for 2025.SPG
Q4 2024 - H1 2025 saw lower sales and earnings, but margins and full-year outlook remain stable.SPG
Q2 2025 - Own-brand growth lifted 9M earnings as FY revenue guidance narrowed to 10%-16%.SPG
Q3 2024 - Q1 2025 saw 8.8% revenue growth, strong margins, and robust Healthcare segment gains.SPG
Q1 2025